Brooks Laboratories AGM resolutions pass with 99.99% shareholder support
- Brooks Laboratories published final e-voting results for its 24th AGM held on September 3, 2026
- All six ordinary resolutions passed with support exceeding 99.99% from participating shareholders
- Total votes polled stood at 18,555,905, representing full participation from promoter and public non-institutional holders
- Key approvals included FY26 financials, director reappointment, and executive remuneration

*this image is generated using AI for illustrative purposes only.
Brooks Laboratories has released the final e-voting results for its 24th Annual General Meeting (AGM), confirming that all six ordinary resolutions were approved by shareholders. The meeting, held on September 3, 2026, via video conference, saw near-unanimous support for the company’s financial statements and management appointments.
The scrutinizer report, issued by G.S. Sarin of Sharma Sarin & Associates on September 4, 2026, details the voting breakdown. A total of 18,555,905 votes were polled across all resolutions, representing 100% of the outstanding shares held by promoters and public non-institutional investors who participated.
Voting Results Breakdown
The voting process was conducted through remote e-voting and e-voting during the AGM. The promoter group held 15,500,292 shares, while public non-institutional shareholders held 3,055,613 shares. No institutional public shareholders voted.
| Resolution | Description | Votes In Favour | Votes Against | % Support |
|---|---|---|---|---|
| 1 | Adoption of FY26 financial statements | 18,555,826 | 79 | 99.9996% |
| 2 | Reappointment of Mr. Jitendra Pratap Singh | 18,555,771 | 134 | 99.9993% |
| 3 | Ratification of cost auditor remuneration | 18,555,826 | 79 | 99.9996% |
| 4 | Approval of related party transactions | 18,555,826 | 79 | 99.9996% |
| 5 | Remuneration for Mr. Atul Ranchal | 10,792,753 | 134 | 99.9988% |
| 6 | Remuneration for Mr. Rajesh Mahajan | 10,818,497 | 134 | 99.9988% |
Key Resolutions Passed
Shareholders approved the adoption of the annual audited standalone and consolidated financial statements for FY26. The reappointment of Mr. Jitendra Pratap Singh as a director, replacing those retiring by rotation, was also ratified.
Additionally, the meeting approved the remuneration for Mr. Atul Ranchal, President – Strategy, and Mr. Rajesh Mahajan, President – Trading, under Section 188(1)(f) of the Companies Act, 2013. Related party transactions and cost auditor remuneration were similarly approved.
Scrutinizer Report Details
The remote e-voting period commenced on August 31, 2026, at 9:00 am and concluded on September 2, 2026, at 5:00 pm. The votes were unblocked on September 3, 2026, in the presence of two independent witnesses. No invalid votes were recorded for Resolutions 1, 2, 3, and 4. For Resolutions 5 and 6, which involved related party interests, some promoter votes were marked invalid due to abstention requirements, though the resolutions still passed with overwhelming support from eligible voters.
Historical Stock Returns for Brooks Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.79% | -10.16% | -20.90% | +47.67% | -59.18% | -58.40% |
How might the near-unanimous shareholder approval of FY26 financial statements influence Brooks Laboratories' credit rating or future borrowing costs?
What strategic initiatives are Mr. Atul Ranchal and Mr. Rajesh Mahajan expected to prioritize following the ratification of their remuneration packages?
Could the complete absence of institutional public shareholders in the voting process signal a shift in investor sentiment or liquidity concerns for Brooks Laboratories?


































